Stay updated on Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.

Latest updates to the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.5.0 was added to the history and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check11 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the history list. This update affects only the revision history entries on the page and does not alter study data or functionality.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedAddition of Revision: v3.4.2 and the removal of the funding/operating status notice are site-wide administrative updates. They do not change the study record, its data, or the core content of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check47 days agoChange DetectedAdded a government funding status notice and updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.6%

- Check54 days agoChange DetectedNew glossary toggle, color-coded diff highlights (green for additions, red for deletions), and a revised revision label (v3.4.0) were added, while the previous revision (v3.3.4) and the 'No FEAR Act Data' text were removed.SummaryDifference0.8%

- Check68 days agoChange DetectedAdded a new Revision: v3.3.4 entry and removed the previous Revision: v3.3.3 entry in the version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.